Suzanne Ward

405 total citations
8 papers, 280 citations indexed

About

Suzanne Ward is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Suzanne Ward has authored 8 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pediatrics, Perinatology and Child Health, 3 papers in Public Health, Environmental and Occupational Health and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Suzanne Ward's work include Acute Lymphoblastic Leukemia research (3 papers), Heart Failure Treatment and Management (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Suzanne Ward is often cited by papers focused on Acute Lymphoblastic Leukemia research (3 papers), Heart Failure Treatment and Management (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Suzanne Ward collaborates with scholars based in United States. Suzanne Ward's co-authors include Richard C. Dart, Gregory M. Bogdan, R. Stephen Porter, Craig S. Kitchens, Steven A. Seifert, Richard F. Clark, Patrick E. McKinney, Jude McNally, Steven C. Curry and Leslie Boyer and has published in prestigious journals such as The Journal of Clinical Pharmacology, JACC Heart Failure and Therapeutic Drug Monitoring.

In The Last Decade

Suzanne Ward

8 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne Ward United States 7 150 106 55 49 37 8 280
Jennifer Gorwood France 9 25 0.2× 79 0.7× 161 2.9× 82 1.7× 10 0.3× 10 381
Caroline Royle United States 9 23 0.2× 51 0.5× 6 0.1× 32 0.7× 35 0.9× 12 441
Sakda Patrapinyokul Thailand 11 48 0.3× 23 0.2× 4 0.1× 45 0.9× 8 0.2× 35 339
Brooks I. Mitchell United States 11 7 0.0× 143 1.3× 107 1.9× 48 1.0× 12 0.3× 27 296
Maggie Hancock United Kingdom 9 21 0.1× 22 0.2× 33 0.6× 90 1.8× 89 2.4× 15 386
Patrice LaBelle United States 11 36 0.2× 25 0.2× 2 0.0× 33 0.7× 29 0.8× 13 402
Beheroze Sattha Canada 11 13 0.1× 117 1.1× 114 2.1× 123 2.5× 7 0.2× 14 410
Rita Romano Italy 10 60 0.4× 6 0.1× 5 0.1× 65 1.3× 31 0.8× 28 343
O Olsson Sweden 9 108 0.7× 9 0.1× 6 0.1× 30 0.6× 13 0.4× 28 302
María Jiménez-González Spain 8 12 0.1× 26 0.2× 20 0.4× 34 0.7× 3 0.1× 24 145

Countries citing papers authored by Suzanne Ward

Since Specialization
Citations

This map shows the geographic impact of Suzanne Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Ward more than expected).

Fields of papers citing papers by Suzanne Ward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Ward. The network helps show where Suzanne Ward may publish in the future.

Co-authorship network of co-authors of Suzanne Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Ward. A scholar is included among the top collaborators of Suzanne Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Ward. Suzanne Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Nelson, Rebecca, et al.. (2023). Glucarpidase for Treating Adults with Delayed Methotrexate Elimination Due to Impaired Renal Function: An Economic Simulation Analysis. ClinicoEconomics and Outcomes Research. Volume 15. 165–179. 5 indexed citations
2.
Demiralp, Berna, et al.. (2019). <p>Length of stay, mortality, and readmissions among Medicare cancer patients treated with glucarpidase and conventional care: a retrospective study</p>. ClinicoEconomics and Outcomes Research. Volume 11. 129–144. 17 indexed citations
3.
Hauptman, Paul J., Steven W. Blume, Eldrin F. Lewis, & Suzanne Ward. (2016). Digoxin Toxicity and Use of Digoxin Immune Fab. JACC Heart Failure. 4(5). 357–364. 29 indexed citations
4.
Adair, C. David, Vardaman M. Buckalew, Steven W. Graves, et al.. (2010). Digoxin Immune Fab Treatment for Severe Preeclampsia. American Journal of Perinatology. 27(8). 655–662. 27 indexed citations
5.
Phillips, M. E., et al.. (2008). Pharmacokinetics of Glucarpidase in Subjects With Normal and Impaired Renal Function. The Journal of Clinical Pharmacology. 48(3). 279–284. 19 indexed citations
6.
Heard, Kennon, Richard C. Dart, Gregory M. Bogdan, et al.. (2006). A Preliminary Study of Tricyclic Antidepressant (TCA) Ovine FAB for TCA Toxicity. Clinical Toxicology. 44(3). 275–281. 16 indexed citations
7.
Dart, Richard C., Steven A. Seifert, Leslie Boyer, et al.. (2001). A Randomized Multicenter Trial of Crotalinae Polyvalent Immune Fab (Ovine) Antivenom for the Treatment for Crotaline Snakebite in the United States. Archives of Internal Medicine. 161(16). 2030–2030. 155 indexed citations
8.
Ward, Suzanne, Lena Sjöström, & Michael R. Ujhelyi. (2000). Comparison of the Pharmacokinetics and In Vivo Bioaffinity of DigiTAb Versus Digibind. Therapeutic Drug Monitoring. 22(5). 599–607. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Gorwood Breakdown of academic impact, for papers by Caroline Royle Breakdown of academic impact, for papers by Sakda Patrapinyokul Breakdown of academic impact, for papers by Brooks I. Mitchell Breakdown of academic impact, for papers by Maggie Hancock Breakdown of academic impact, for papers by Patrice LaBelle Breakdown of academic impact, for papers by Beheroze Sattha Breakdown of academic impact, for papers by Rita Romano Breakdown of academic impact, for papers by O Olsson Breakdown of academic impact, for papers by María Jiménez-González
Rankless by CCL
2026